Cancers combined with chemotherapy anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells Neoplastic Stem Cells MCF-7 Cells HT29 Cells Cell Line

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases50

Radiation Injuries Neoplasms Breast Neoplasms Lung Neoplasms Ovarian Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasm Recurrence, Local Stomach Neoplasms Carcinoma, Non-Small-Cell Lung Adenocarcinoma Prostatic Neoplasms Carcinoma, Squamous Cell Neoplasms, Radiation-Induced Pancreatic Neoplasms Colorectal Neoplasms Carcinoma Neoplasm Invasiveness Brain Neoplasms Radiation Pneumonitis Liver Neoplasms Head and Neck Neoplasms Radiation Injuries, Experimental Disease Progression Bone Neoplasms Uterine Cervical Neoplasms Urinary Bladder Neoplasms Rectal Neoplasms Testicular Neoplasms Neoplasms, Experimental Esophageal Neoplasms Neutropenia Hodgkin Disease Lymphoma, Non-Hodgkin Neoplasms, Second Primary Neovascularization, Pathologic Nausea Melanoma Vomiting Lymphoma Cell Transformation, Neoplastic Peritoneal Neoplasms Skin Neoplasms Osteosarcoma Genetic Predisposition to Disease Recurrence Glioblastoma Glioma Neoplasms, Germ Cell and Embryonal Leukemia

Chemicals and Drugs75

Antineoplastic Agents Cisplatin Doxorubicin Antineoplastic Agents, Phytogenic Etoposide Cyclophosphamide Paclitaxel Antibiotics, Antineoplastic Antimetabolites, Antineoplastic Camptothecin Organoplatinum Compounds Vinblastine Taxoids Methotrexate Carboplatin Deoxycytidine Neoplasm Proteins Bleomycin Antineoplastic Agents, Alkylating Drug Carriers Tumor Markers, Biological Radiation-Sensitizing Agents Tumor Suppressor Protein p53 P-Glycoprotein Anthracyclines Mitomycin Daunorubicin Mitoxantrone Platinum Fluorouracil RNA, Messenger Antibodies, Monoclonal Receptor, erbB-2 RNA, Small Interfering Ellipticines Cancer Vaccines DNA, Neoplasm Enzyme Inhibitors Antibodies, Monoclonal, Humanized Cytarabine Dacarbazine Receptors, Estrogen Proto-Oncogene Proteins c-bcl-2 Prodrugs Ifosfamide Tamoxifen Anticarcinogenic Agents DNA-Binding Proteins Platinum Compounds Radiation-Protective Agents Plant Extracts Caspases Tegafur Protein Kinase Inhibitors Receptor, Epidermal Growth Factor Carmustine Topoisomerase I Inhibitors Caspase 3 DNA Topoisomerases, Type II Antigens, Neoplasm Quinazolines Melphalan Antineoplastic Agents, Hormonal DNA Tumor Suppressor Proteins Floxuridine Radiopharmaceuticals Nimustine Multidrug Resistance-Associated Proteins Receptors, Progesterone Topotecan Nanocapsules Prostate-Specific Antigen Adjuvants, Pharmaceutic Protein-Serine-Threonine Kinases

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Radiation Dosage Combined Modality Therapy Dose-Response Relationship, Radiation Drug Screening Assays, Antitumor Treatment Outcome Radiation Monitoring Survival Analysis Disease-Free Survival Neoplasm Staging Prognosis Survival Rate Radiotherapy Xenograft Model Antitumor Assays Early Detection of Cancer Drug Delivery Systems Drug Administration Schedule Neoadjuvant Therapy Radiotherapy Dosage Follow-Up Studies Clinical Trials as Topic Radiotherapy, Adjuvant Drug Carriers Neoplasm Transplantation Prospective Studies Radiation Injuries, Experimental Inhibitory Concentration 50 Molecular Targeted Therapy Blotting, Western Tumor Burden Kaplan-Meier Estimate Reverse Transcriptase Polymerase Chain Reaction Transplantation, Heterologous Induction Chemotherapy Gene Expression Profiling Radiometry Drug Design Flow Cytometry Neoplasms, Experimental Models, Biological Risk Assessment Salvage Therapy Palliative Care Multivariate Analysis Dose Fractionation Drug Evaluation, Preclinical Tomography, X-Ray Computed Risk Risk Factors Retrospective Studies Chemoradiotherapy Transfection Hyperthermia, Induced Chemotherapy, Cancer, Regional Perfusion Immunohistochemistry Sensitivity and Specificity Predictive Value of Tests Infusions, Intravenous Mastectomy Cranial Irradiation Radiotherapy, Conformal Oligonucleotide Array Sequence Analysis Registries Transplantation, Autologous Positron-Emission Tomography Feasibility Studies Reproducibility of Results Drug Discovery Tumor Stem Cell Assay Administration, Oral Nanocapsules Clinical Trials, Phase I as Topic Immunotherapy

Phenomena and Processes41

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Drug Resistance, Neoplasm Radiation Apoptosis Cell Survival Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Cell Proliferation Time Factors DNA Damage Gamma Rays Cell Cycle Drug Synergism Drug Resistance, Multiple Cosmic Radiation Inhibitory Concentration 50 Mutation Cell Division Ultraviolet Rays DNA Repair Background Radiation Signal Transduction Down-Regulation Molecular Structure Risk Transfection Radiation Effects Sensitivity and Specificity Cell Death Cell Growth Processes Up-Regulation RNA Interference Genetic Predisposition to Disease Base Sequence Genes, p53 Phosphorylation Drug Resistance Gene Expression

Disciplines and Occupations6

Radiation Oncology Medical Oncology Drug Design Immunohistochemistry Nanomedicine Drug Discovery

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Technology, Industry, Agriculture3

Nanoparticles Nanomedicine Nanocapsules

Humanities1

Quality of Life

Information Science5

Survival Rate Molecular Sequence Data Base Sequence Radiotherapy, Conformal Registries

Named Groups1

Health Care31

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Treatment Outcome Radiation Protection Radiation Monitoring Survival Analysis Disease-Free Survival Survival Rate Follow-Up Studies Clinical Trials as Topic Prospective Studies Cosmic Radiation Radiation Injuries, Experimental Kaplan-Meier Estimate Ultraviolet Rays National Cancer Institute (U.S.)Risk Assessment Palliative Care Multivariate Analysis Age Factors Risk Risk Factors Retrospective Studies Radiation Effects Sensitivity and Specificity Predictive Value of Tests Registries Feasibility Studies Reproducibility of Results Clinical Trials, Phase I as Topic

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Chemotherapy, Adjuvant Radiation Dosage Radiation, Ionizing Radiation Injuries Cisplatin Neoplasms Combined Modality Therapy Doxorubicin Cell Line, Tumor Dose-Response Relationship, Radiation Breast Neoplasms Drug Screening Assays, Antitumor Radiation Tolerance Drug Resistance, Neoplasm Radiation Lung Neoplasms Treatment Outcome Antineoplastic Agents, Phytogenic Etoposide Cyclophosphamide Radiation Protection Apoptosis Paclitaxel Radiation Monitoring Survival Analysis Disease-Free Survival Ovarian Neoplasms Mice, Nude Antibiotics, Antineoplastic Cell Survival Neoplasm Staging Prognosis Survival Rate Radiotherapy Xenograft Model Antitumor Assays Colonic Neoplasms Neoplasm Metastasis Antimetabolites, Antineoplastic Neoplasm Recurrence, Local Tumor Cells, Cultured Gene Expression Regulation, Neoplastic Early Detection of Cancer Drug Delivery Systems Drug Administration Schedule Dose-Response Relationship, Drug Camptothecin Stomach Neoplasms Carcinoma, Non-Small-Cell Lung Organoplatinum Compounds Radiation Oncology Vinblastine Taxoids Neoadjuvant Therapy Radiotherapy Dosage Methotrexate Adenocarcinoma Carboplatin Prostatic Neoplasms Deoxycytidine Follow-Up Studies Cell Proliferation Carcinoma, Squamous Cell Neoplasms, Radiation-Induced Pancreatic Neoplasms Time Factors DNA Damage Neoplasm Proteins Colorectal Neoplasms Bleomycin Clinical Trials as Topic Antineoplastic Agents, Alkylating Carcinoma Radiotherapy, Adjuvant Drug Carriers Tumor Markers, Biological Gamma Rays Radiation-Sensitizing Agents Tumor Suppressor Protein p53 Neoplasm Invasiveness Cell Cycle Drug Synergism Brain Neoplasms Radiation Pneumonitis Drug Resistance, Multiple Neoplasm Transplantation Prospective Studies P-Glycoprotein Anthracyclines Cosmic Radiation Liver Neoplasms Head and Neck Neoplasms Radiation Injuries, Experimental Disease Progression Mitomycin Inhibitory Concentration 50 Daunorubicin Mitoxantrone Molecular Targeted Therapy

No FAQ available that match "cancers combined with chemotherapy anticancer drugs or radiation"